Year in Review: Psoriatic Arthritis
The year 2021 saw additional advances and refinements in the treatment of psoriatic arthritis (PsA), a heterogeneous condition that in the past has lagged behind rheumatoid arthritis (RA) in therapeutic progress. But improved understanding of the pathogenesis of PsA has allowed more targeted, safer, and more effective treatment approaches. In particular, data have begun to […]